Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Hydrotalcite and esomeprazole for gastric ulcer healing quality
ChiCTR-IPR-16008317Phase 4Recruiting
- Sponsor
- Department of Digestive Diseases, Zhujiang Hospital of Southern Medical University
- Start
- Jun 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of hydrotalcite and esomeprazole in gastric ulcer (3 arms), sponsored by Department of Digestive Diseases, Zhujiang Hospital of Southern Medical University. Primary endpoints: Composition of collagen fibers, Expression of Factor VIII and 2 more. Started Jun 2014; status: recruiting.
02
Drugs
hydrotalciteesomeprazole
03
Conditions
gastric ulcer
Beyond the preview
Go deeper on ChiCTR-IPR-16008317.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-IPR-16008317.